Fingerprint
Dive into the research topics of 'Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): An Eastern Cooperative Oncology Group Study (E3A98)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): An Eastern Cooperative Oncology Group Study (E3A98)
Morie A. Gertz, Montserrat Rue, Emily Blood, Lynne S. Kaminer, David H. Vesole, Philip R. Greipp
Research output: Contribution to journal › Article › peer-review
158
Scopus
citations